Prosecution Insights
Last updated: May 29, 2026

Evelo Biosciences Inc.

6 pending office actions • 4 art units • 5 examiners • 0 of 6 (0%) have an AI response strategy ready

Portfolio Summary

6
Total Pending OAs
4
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

5
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (5)Due ≤ 30 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
6
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only5 (83%)
§102 only1 (17%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
JACKSON-TONGUE, LAKIA J 2 68.8% +20.4%
ARIANI, KADE 1 74.5% +33.1%
EIX, EMILY FAY 1 52.2% +64.7%
SHAHNAN SHAH, KHATOL S 1 62.6% +53.8%
MOAZZAMI, NAGHMEH NINA 1 71.7% +42.8%

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18285890 PHARMACEUTICAL COMPOSITION CONTAINING BACTERIA JACKSON-TONGUE, LAKIA J 99d overdue
17613341 METHODS AND COMPOSITIONS FOR ANAEROBIC BACTERIAL FERMENTATION MOAZZAMI, NAGHMEH NINA 89d overdue
17780819 METHODS AND COMPOSITIONS FOR CULTURING HEMOGLOBIN-DEPENDENT BACTERIA EIX, EMILY FAY 52d overdue
17632449 METHODS AND COMPOSITIONS FOR CULTURING HEMOGLOBIN-DEPENDENT BACTERIA SHAHNAN SHAH, KHATOL S 43d overdue
18027003 SOLID DOSAGE FORMS OF BACTERIA JACKSON-TONGUE, LAKIA J 4d overdue
18034202 COMPOSITIONS COMPRISING SPIRULINA COMPONENTS ARIANI, KADE 29d

Top Art Units

Art UnitApps
1645 3
1651 1
1653 1
1652 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18285890 PHARMACEUTICAL COMPOSITION CONTAINING BACTERIA JACKSON-TONGUE, LAKIA J 1645 §102 Non-Final OA 99d overdue Pending Oct 06, 2023
18034202 COMPOSITIONS COMPRISING SPIRULINA COMPONENTS ARIANI, KADE 1651 §103 Non-Final OA 29d Pending Apr 27, 2023
18027003 SOLID DOSAGE FORMS OF BACTERIA JACKSON-TONGUE, LAKIA J 1645 §103 Non-Final OA 4d overdue Pending Mar 17, 2023
17780819 METHODS AND COMPOSITIONS FOR CULTURING HEMOGLOBIN-DEPENDENT BACTERIA EIX, EMILY FAY 1653 §103 Final Rejection 52d overdue Pending May 27, 2022
17632449 METHODS AND COMPOSITIONS FOR CULTURING HEMOGLOBIN-DEPENDENT BACTERIA SHAHNAN SHAH, KHATOL S 1645 §103 Final Rejection 43d overdue Pending Feb 02, 2022
17613341 METHODS AND COMPOSITIONS FOR ANAEROBIC BACTERIAL FERMENTATION MOAZZAMI, NAGHMEH NINA 1652 §103 Non-Final OA 89d overdue Pending Nov 22, 2021

Managing Evelo Biosciences Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month